510(k) Report

510(k) · Cleared

Cleared

Liquichek Lipids Control Level 1, Liquichek Lipids Control Level 2, Models 641 and 642

K012513510(k) TraditionalCleared Aug 29, 200123-day reviewClass I21 CFR 862.1660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Rad · JJY Multi-Analyte Controls, All Kinds (Assayed)

Cleared on Aug 29, 2001 as substantially equivalent to K002460 (Bio-Rad, 2000) after a 23-day review. Its family tree reaches back 1 generation to 2000. 4 later devices descend from it.

Decided
Aug 29, 2001
Review
23 days
Class
Class I
Product code
JJY
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K002460 (2000). 4 later devices descend from it, 4 citing it directly.

Descendants, by year cleared 2004: 1 descendant cleared2010: 1 descendant cleared2011: 1 descendant cleared2008: 1 descendant clearedK002460 · Liquichek Lipids Control, Model 641, 642 · Bio-Rad · 2000200020052010201520202025
Descendants, by generation 1 generation forward: 4 descendants K002460 · Liquichek Lipids Control, Model 641, 642 · Bio-Rad · 20000
  1. Root · 1 generation backK002460 Liquichek Lipids Control, Model 641, 642Bio-Rad · 2000
  2. This deviceK012513 Liquichek Lipids Control Level 1, Liquichek Lipids Control Level 2…Bio-Rad · 2001
  3. Descendant · cites it directly · 1 of its ownK082067 MSC Lipid ControlMaine Standards Co. · 2008
  4. Descendant · cites it directly · 0 of its ownK103271 MSC Lipid ControlMaine Standards Co. · 2011
  5. Descendant · cites it directly · 0 of its ownK101226 Audit Microcv RF/CRP Linearity SetAalto Scientific, Ltd. · 2010
  6. Descendant · cites it directly · 0 of its ownK042837 Liquichek Elevated CRP ControlBio-Rad · 2004

Most influential descendants

Showing 4 of 4 · See all
  • K082067MSC Lipid ControlMaine Standards Co. · 2008 · cites it directly1descendant
  • K103271MSC Lipid ControlMaine Standards Co. · 2011 · cites it directly0descendants
  • K101226Audit Microcv RF/CRP Linearity SetAalto Scientific, Ltd. · 2010 · cites it directly0descendants
  • K042837Liquichek Elevated CRP ControlBio-Rad · 2004 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K002460Liquichek Lipids Control, Model 641, 642Bio-Rad2000—
0 (this device)K012513Liquichek Lipids Control Level 1, Liquichek Lipids Control Level 2, Models 641…Bio-Rad2001—
+1K082067MSC Lipid ControlMaine Standards Co.2008—
+1K103271MSC Lipid ControlMaine Standards Co.2011—
+1K101226Audit Microcv RF/CRP Linearity SetAalto Scientific, Ltd.2010—
+1K042837Liquichek Elevated CRP ControlBio-Rad2004—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
200810
201010
201110
FIG. 1 — Lineage of K012513, 2000–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JJY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K002460Liquichek Lipids Control, Model 641, 642
Summary page 1
…egulation Number: CFR 862.1660 3.0 Device to Which Substantial Equivalence is Claimed Liquichek™ Lipids Control Bio-Rad Laboratories Irvine, California Docket Number: K002460 4.0 Description of Device Liquichek™ Lipids Control is prepared from human serum with added constituents of human and animal or…
Bio-Rad2000—

What descends from it? (4)

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K082067MSC Lipid ControlMaine Standards Co.20081
K103271MSC Lipid ControlMaine Standards Co.20110
K101226Audit Microcv RF/CRP Linearity SetAalto Scientific, Ltd.20100
K042837Liquichek Elevated CRP ControlBio-Rad20040

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K082067 (Maine Standards Co., 2008) has gone furthest, with 1 descendant of its own.

How does its category compare?

All JJY devices

JJY Multi-Analyte Controls, All Kinds (Assayed): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JJY

3in 2017

2007: 112008: 72009: 82010: 102011: 142012: 132013: 162014: 102015: 42016: 12017: 3
2007high 16 (2013) · low 0 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JJY

78in 2017

2007: 49 days median2008: 54 days median2009: 80 days median2010: 109 days median2011: 120 days median2012: 40 days median2013: 82 days median2014: 49 days median2015: 153 days median2017: 78 days median
2007high 153 (2015) · low 40 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JJY

2in 2025

2007: 52009: 22010: 62011: 12012: 32013: 22014: 22015: 12016: 32017: 42018: 32019: 42020: 62022: 32023: 32025: 22026 (partial year): 1
2007high 6 (2010) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JJY

13in 2025

2007: 22008: 12009: 32010: 32011: 62012: 202013: 52014: 42015: 42016: 132017: 122018: 72019: 12020: 72021: 12023: 42024: 12025: 13
2007high 20 (2012) · low 0 (2022)2025

MAUDE reports naming product code JJY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007114952
200875401
200988023
20101010963
20111412016
20121340320
2013168225
2014104924
2015415314
20161—313
2017378412
20180—37
20190—41
20200—67
20210—01
20220—30
20230—34
20240—01
20250—213
20260—1—

What is it indicated for?

Assayed quality control serum to monitor the precision of laboratory testing procedures for the analytes listed in the package insert

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K012513: Liquichek Lipids Control Level 1, Liquichek Lipids Control Level 2, Models 641 and 642.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K012513

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026